Climb Bio, Inc. CLYM Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.36M-71.2% | $35.69M-59.1% | $25.8M-82.3% | $22.68M-89.8% | $29.02M-72.4% | ||
| $101.21M+46.6% | $65.4M+2.7% | $61.1M+29.5% | $62.02M— | $69.04M— | ||
| $113.4M+13.1% | $105.85M-31.7% | $90.96M-54.0% | $87.38M-61.3% | $100.28M-8.2% | ||
| $250K— | —— | —— | —— | —— | ||
| $152.37M-24.1% | $167.74M-22.8% | $182.3M-18.0% | $192.39M-14.9% | $200.74M+83.6% | ||
| $4.55M+99.5% | $4.47M+181% | $2.91M+205% | $2.72M+94.8% | $2.28M+29.3% | ||
| $4.07M-42.1% | $6.98M+41.6% | $4.95M+44.6% | $6.21M+65.9% | $7.04M+139% | ||
| $4.29M-41.7% | $7.27M+37.0% | $5.3M+54.9% | $6.62M+77.0% | $7.36M+149% | ||
| $5K-28.6% | $5K-28.6% | $7K0.0% | $7K0.0% | $7K+133% | ||
| -$303.45M-21.1% | -$289.73M-26.0% | -$272.21M-22.9% | -$259.32M-22.0% | -$250.66M-59.0% | ||
| $148.09M-23.4% | $160.48M-24.3% | $177M-19.1% | $185.76M-16.4% | $193.39M+81.8% | ||
| $152.37M-24.1% | $167.74M-22.8% | $182.3M-18.0% | $192.39M-14.9% | $200.74M+83.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Climb Bio, Inc.'s total assets?
- Climb Bio, Inc. (CLYM) holds $152.4M in total assets, down 24.1% year over year.
- How much debt does Climb Bio, Inc. have?
- Climb Bio, Inc. carries $479.0K in total debt against $148.1M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Climb Bio, Inc. have?
- Climb Bio, Inc. holds $8.4M in cash and equivalents.
- Can Climb Bio, Inc. cover its short-term obligations?
- Its current ratio is 27.86 — current assets exceed current liabilities.
- Where does Climb Bio, Inc.'s balance sheet data come from?
- Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.